chr2-3478848-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_016030.6(TRAPPC12):c.1880C>T(p.Ala627Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_016030.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAPPC12 | NM_016030.6 | c.1880C>T | p.Ala627Val | missense_variant, splice_region_variant | 11/12 | ENST00000324266.10 | NP_057114.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAPPC12 | ENST00000324266.10 | c.1880C>T | p.Ala627Val | missense_variant, splice_region_variant | 11/12 | 1 | NM_016030.6 | ENSP00000324318.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251372Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135860
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461750Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727184
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74330
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2022 | The c.1880C>T (p.A627V) alteration is located in exon 11 (coding exon 10) of the TRAPPC12 gene. This alteration results from a C to T substitution at nucleotide position 1880, causing the alanine (A) at amino acid position 627 to be replaced by a valine (V). Based on data from gnomAD, the T allele has an overall frequency of 0.001% (2/251372) total alleles studied. The highest observed frequency was 0.006% (2/34580) of Latino alleles. The c.1880C>T (p.A627V) alteration was reported in trans with a frameshift alteration in a pair of siblings who presented with a severe neurodevelopmental disorder consisting of global developmental delay with regression, truncal hypotonia, appendicular spasticity, cortical visual impairment, hearing loss, microcephaly, feeding difficulties, hearing loss, pons hypoplasia, agenesis of the corpus callosum, and marked brain atrophy (Milev, 2017). The c.1880C>T (p.A627V) was also detected in the homozygous state in an individual with severe global developmental delay, axial hypotonia, appendicular hypertonia, feeding difficulties, seizures, congenital microcephaly, ventriculomegaly, progressive severe cerebral atrophy, moderate cerebellar atrophy, and simplified frontal gyri (Aslanger, 2020). This amino acid position is highly conserved in available vertebrate species. The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as likely pathogenic. - |
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 18, 2017 | - - |
Progressive childhood encephalopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | May 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at